Comparison of Analgesic Methods, and Their Effects on Patient Recovery, Following Liver Surgery
NCT ID: NCT01042054
Last Updated: 2015-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2009-07-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Commonly, pain relief in the first few days after surgery is provided by epidural analgesia. Drugs are delivered to the area around the spinal cord, through a fine plastic tube placed in the patients back, and this blocks sensation from the abdomen downwards, thereby providing effective pain relief without the need for opiate analgesia (e.g. morphine). Opiate analgesia can cause nausea, drowsiness and constipation, and its use should be minimised. Epidurals, however, can be associated with some problematic side effects. Low blood pressure is commonly encountered, and not only can its treatment be associated with complications, but patients are often confined to bed.
Mobility can also be limited if muscle function in the legs, (in addition to sensation), is inadvertently affected by the epidural drugs. Other problems associated with epidural use are the relatively common failure of the technique to provide adequate analgesia (20%), and some extremely rare but potentially disastrous complications of epidural insertion.
An alternative technique, is the provision of pain relief directly into the wound, via one or more multi-holed tubes(catheters), placed either in or close to the wound. This technique alone does not provide as effective analgesia as a functioning epidural, but when combined with other intravenous or oral analgesia, has been shown to be effective following a variety of surgical procedures.
It is hypothesised that, following major liver surgery, the use of this latter technique may result in superior outcome and faster recovery, when compared with epidural, by avoidance of the side effects and complications discussed above.
In this study, patients scheduled to undergo major liver surgery at the Royal Infirmary of Edinburgh with be randomly assigned to receive the first two days of pain relief either by epidural, or by wound catheter plus additional analgesia. Both groups will then receive an identical oral analgesic regime for the remainder of the hospital stay.
Outcomes of interest will include the quality of pain relief attained, patient mobility, frequency of complications, and overall recovery time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver Resection
NCT03813953
Epidural vs. Wound Catheter Following Liver Resection
NCT03638401
Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy
NCT06778460
Effect of Epidural Anesthesia and Analgesia on Patients' Outcomes After Liver Resection
NCT01617811
Analgesic Effect of Intrathecal Morphine Combined With Low Dose Local Anesthetics on Postoperative Analgesia After Liver Resection
NCT05208801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epidural
Patients will follow a standard optimised recovery protocol, including epidural analgesia for the first 48 hours postoperatively.
Standard optimised recovery protocol.
* Epidural analgesia for the first 48 hours postoperatively.
* Sham wound catheter attached to anterior abdominal wall, for purposes of blinding.
* Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital.
* Optimised recovery protocol followed throughout.
Wound catheter
Patients will follow a standard optimised recovery protocol, but analgesia in the first 48 hours will be delivered through local anaesthetic wound catheters and additional patient-controlled analgesia, instead of epidural analgesia.
Wound catheter plus patient-controlled analgesia.
* Continuous infusion of local anaesthetic administered via wound catheters for the first 48 hours postoperatively.
* Additional patient-controlled intravenous opiate analgesia available to patient during this time period.
* Sham epidural catheter applied to the patient's back for purposes of blinding.
* Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital.
* Optimised recovery protocol followed throughout.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard optimised recovery protocol.
* Epidural analgesia for the first 48 hours postoperatively.
* Sham wound catheter attached to anterior abdominal wall, for purposes of blinding.
* Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital.
* Optimised recovery protocol followed throughout.
Wound catheter plus patient-controlled analgesia.
* Continuous infusion of local anaesthetic administered via wound catheters for the first 48 hours postoperatively.
* Additional patient-controlled intravenous opiate analgesia available to patient during this time period.
* Sham epidural catheter applied to the patient's back for purposes of blinding.
* Standard oral analgesic regime commenced at 48 hours, and continued until discharge from hospital.
* Optimised recovery protocol followed throughout.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand the nature of the study and what will be required of them.
* Men and non-pregnant, non-lactating women.
* BMI 18-40.
Exclusion Criteria
* Inability to give written, informed consent.
* Patients with dementia or neurological impairment.
* Patients with pre-existing condition limiting mobility.
* Underlying cirrhotic liver disease.
* Jaundice (Bilirubin \> 50 μmol/L).
* Liver resection combined with secondary surgical procedure.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Lothian
OTHER_GOV
University of Edinburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erica Revie
Miss Erica Revie
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erica J Revie
Role: PRINCIPAL_INVESTIGATOR
University of Edinburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Surgery, Royal Infirmary of Edinburgh
Edinburgh, Midlothian, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Revie EJ, McKeown DW, Wilson JA, Garden OJ, Wigmore SJ. Randomized clinical trial of local infiltration plus patient-controlled opiate analgesia vs. epidural analgesia following liver resection surgery. HPB (Oxford). 2012 Sep;14(9):611-8. doi: 10.1111/j.1477-2574.2012.00490.x. Epub 2012 Jun 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009/R/SU/04
Identifier Type: OTHER
Identifier Source: secondary_id
09/S1102/17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.